BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25344970)

  • 1. [Diagnostic importance of pentraxins at the early phase of acute pancreatitis].
    Meryk P; Dumnicka P; Kuśnierz-Cabala B; Kuźniewski M; Kapusta M; Gurda-Duda A; Goebels M; Pawlica-Gosiewska D; Kulig J
    Przegl Lek; 2014; 71(6):309-13. PubMed ID: 25344970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of selected inflammatory markers for early prediction of severe clinical course of acute pancreatitis].
    Kuśnierz-Cabala B; Gurda-Duda A; Dumnicka P; Kuźniewski M; Kulig J; Panek J; Solnica B
    Przegl Lek; 2013; 70(6):392-6. PubMed ID: 24052976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
    Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
    Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis.
    Dumnicka P; Zylka A; Kusnierz-Cabala B; Gurda-Duda A; Kuzniewski M; Drozdz R; Kulig J
    Folia Med Cracov; 2014; 54(2):17-26. PubMed ID: 25648306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of hepatocyte growth factor at early phase of acute pancreatitis.
    Sporek M; Kolber W; Kusnierz-Cabala B; Dumnicka P; Gurda-Duda A; Kuzniewski M; Solnica B; Kulig J
    Folia Med Cracov; 2013; 53(1):87-95. PubMed ID: 24858334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pentraxin 3 concentrations in patients with acute pancreatitis.
    Kusnierz-Cabala B; Gurda-Duda A; Dumnicka P; Panek J; Pawlica-Gosiewska D; Kulig J; Solnica B
    Clin Lab; 2013; 59(9-10):1003-8. PubMed ID: 24273922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant.
    Rau B; Steinbach G; Baumgart K; Gansauge F; Grünert A; Beger HG
    Crit Care Med; 2000 Mar; 28(3):736-42. PubMed ID: 10752823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.
    Lech M; Rommele C; Anders HJ
    Nephrol Dial Transplant; 2013 Apr; 28(4):803-11. PubMed ID: 23243042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute phase proteins in salmonids: evolutionary analyses and acute phase response.
    Jensen LE; Hiney MP; Shields DC; Uhlar CM; Lindsay AJ; Whitehead AS
    J Immunol; 1997 Jan; 158(1):384-92. PubMed ID: 8977214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the prognostic value of certain acute-phase proteins and procalcitonin in the prognosis of acute pancreatitis.
    Gurda-Duda A; Kuśnierz-Cabala B; Nowak W; Naskalski JW; Kulig J
    Pancreas; 2008 Nov; 37(4):449-53. PubMed ID: 18953261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long pentraxin PTX3 in vascular pathology.
    Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
    Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
    Norata GD; Garlanda C; Catapano AL
    Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases.
    Fukuda T; Kurano M; Iida H; Takano H; Tanaka T; Yamamoto Y; Ikeda K; Nagasaki M; Monzen K; Uno K; Kato M; Shiga T; Maemura K; Masuda N; Yamashita H; Hirata Y; Nagai R; Nakajima T
    Eur J Prev Cardiol; 2012 Dec; 19(6):1393-400. PubMed ID: 21914683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
    Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
    Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the diagnostic accuracy of plasma markers for early diagnosis in patients suspected for acute appendicitis.
    Schellekens DH; Hulsewé KW; van Acker BA; van Bijnen AA; de Jaegere TM; Sastrowijoto SH; Buurman WA; Derikx JP
    Acad Emerg Med; 2013 Jul; 20(7):703-10. PubMed ID: 23859584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum matrix Gla protein concentrations in patients with mild and severe acute pancreatitis.
    Kusnierz-Cabala B; Gurda-Duda A; Solnica B; Fedak D; Dumnicka P; Panek J; Kulig J
    Clin Lab; 2011; 57(11-12):999-1006. PubMed ID: 22239033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor?].
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Aug; 42(2):49-56. PubMed ID: 12964514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis.
    Staubli SM; Schäfer J; Rosenthal R; Zeindler J; Oertli D; Nebiker CA
    Sci Rep; 2019 Dec; 9(1):18340. PubMed ID: 31798002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein].
    Shimetani N; Ichikawa K; Hachimura K; Tanaka T; Ohtani S; Kanoh Y; Ohtani H
    Rinsho Byori; 1996 Jul; 44(7):669-75. PubMed ID: 8741497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory markers predicting severity of acute pancreatitis.
    Staubli SM; Oertli D; Nebiker CA
    Crit Rev Clin Lab Sci; 2015; 52(6):273-83. PubMed ID: 26173077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.